(Total Views: 135)
Posted On: 11/02/2022 1:10:50 PM
Post# of 47163

$SRDX News Article - 24-Month Data from Surmodics' TRANSCEND Trial Presented at VIVA 2022 Conference https://marketwirenews.com/news-releases/24-m...39135.html


My Twitter: WhyteStocks